SCHEMBL960356

SCHEMBL960356

CC(C)(C)OC(=O)N1C(=O)C=C[C@@H]1CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 2/20 0.34
DUT P33316 1/20 0.34
FKBP1A P62942 1/20 0.34
NFKB1 P19838 2/20 0.33
NFKB2 Q00653 2/20 0.33
RELA Q04206 2/20 0.33
NR1H2 P55055 1/20 0.33
HTT P42858 1/20 0.32
ATM Q13315 1/20 0.32
FAAH O00519 1/20 0.32
KLK7 P49862 2/20 0.32
KLK5 Q9Y337 1/20 0.32
ALDH1A1 P00352 1/20 0.32
ELANE P08246 1/20 0.32
SETD7 Q8WTS6 1/20 0.31
NAMPT P43490 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
GPR119 Q8TDV5 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2504329 1.00 TOP2A (0.34) TOP2ADUTFKBP1ANFKB1NFKB2
SCHEMBL190828 1.00 TOP2A (0.34) TOP2ADUTFKBP1ANFKB1NFKB2
SCHEMBL3739744 0.85 DUT (0.36) TOP2ADUTFKBP1A
SCHEMBL3628010 0.85 DUT (0.36) TOP2ADUTFKBP1A
SCHEMBL15957013 0.85 DUT (0.36) TOP2ADUTFKBP1A
SCHEMBL14273543 0.84 DUT (0.36) TOP2ADUTFKBP1A
SCHEMBL2738382 0.82 KLK7 (0.34) NFKB1NFKB2RELANR1H2KLK7
SCHEMBL15317919 0.81 SMYD2 (0.40) HTTKLK7KLK5NAMPTKDM4E
SCHEMBL8595433 0.81 SMYD2 (0.40) HTTKLK7KLK5NAMPTKDM4E
SCHEMBL15320368 0.81 ALDH1A1 (0.38) TOP2ADUTFKBP1ANFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235389-A1 P53 MODULATORS NESTED THERAPEUTICS, INC. (US) 2025-11-13 WO disclosed
WO-2024215802-A1 BENZOFURANYL AND BENZOTHIENYL COMPOUNDS AS P53 MODULATORS NESTED THERAPEUTICS, INC. (US) 2024-10-17 WO disclosed
US-20110015238-A1 BLOOD FLOW PROMOTERS FOR CAUDA EQUINA TISSUES ONO PHARMACEUTICAL CO., LTD. (JP) 2011-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015238-A1 BLOOD FLOW PROMOTERS FOR CAUDA EQUINA TISSUES PTGFR, PTGIS, PTGIR TOP2A 2566/4885DUT 1245/4885FKBP1A 1008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.